TLR5: A prognostic and monitoring indicator for triple-negative breast cancer

A novel, highly selective biomarker is urgently needed to predict and monitor triple-negative breast cancer (TNBC) because targeting molecules are not currently available. Although associated with various malignant tumors, the role of toll-like receptor 5 (TLR5) in TNBC remains uncertain. We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Dai, Zhao, Shanshan, Jiang, Wen, Zhang, Chao, Liang, Ting, Hou, Guihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920449/
https://www.ncbi.nlm.nih.gov/pubmed/31852883
http://dx.doi.org/10.1038/s41419-019-2187-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920449/
https://www.ncbi.nlm.nih.gov/pubmed/31852883
http://dx.doi.org/10.1038/s41419-019-2187-8

Ejemplares similares